Original Publication Date: 28 June, 2016
Publication / Source: Bioanalysis 8(14)00
Authors: Battista M-C, Boutin M, Venne P et al.
Background: Despite recommendations to use inhaled corticosteroids as treatment to control asthma during pregnancy, it is unknown whether inhaled fluticasone propionate (FP) reaches the fetus. Results & methodology: We collected maternal blood on the morning following delivery. FP was detected by ultra-performance LC–MS/MS (UPLC–MS/MS) in 9/17 asthmatic women using FP. Delay between last FP inhalation and maternal blood sampling ranged between 3 and 33 h and FP was detected in a range of 1.572–46.440 pg/ml. Among the nine offspring of these FP users, FP was detected in five cord blood samples. Delay between last predelivery FP inhalation and cord blood sampling ranged from 4 to 20 h and FP was detected in a range of 0.423–4.510 pg/ml. Conclusion: Our findings demonstrate placental passage of inhaled FP.